Stockscreener 앱 받기
78.23
3.34%
-2.70
시간 외 거래:
78.22
-0.01
-0.01%
전일 마감가:
$80.93
열려 있는:
$81.11
하루 거래량:
9.86M
Relative Volume:
0.98
시가총액:
$100.14B
수익:
$36.36B
순이익/손실:
$4.84B
주가수익비율:
21.02
EPS:
3.7212
순현금흐름:
$5.43B
1주 성능:
-2.98%
1개월 성능:
+5.99%
6개월 성능:
-18.56%
1년 성능:
-10.26%
1일 변동 폭
$78.14
$81.20
1주일 범위
$78.14
$82.48
52주 변동 폭
$73.31
$106.33
메드트로닉 Stock (MDT) Company Profile
명칭
Medtronic Plc
전화
01135314381700
주소
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
78.23 | 103.66B | 36.36B | 4.84B | 5.43B | 3.7212 |
ABT
Abbott Laboratories
|
90.74 | 163.94B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
314.84 | 127.55B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.68 | 65.74B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.46 | 52.27B | 6.30B | 1.07B | 1.09B | 1.8406 |
메드트로닉 Stock (MDT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-13 | 재개 | Barclays | Overweight |
| 2026-02-09 | 업그레이드 | Needham | Hold → Buy |
| 2026-02-03 | 재개 | Citigroup | Buy |
| 2026-01-30 | 재개 | Wells Fargo | Overweight |
| 2026-01-06 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2025-11-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2025-06-30 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-03-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-10-10 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | 재확인 | Oppenheimer | Perform |
| 2024-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2024-08-14 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Sell |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | 다운그레이드 | UBS | Buy → Sell |
| 2023-01-09 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-11-23 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-11-16 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-08-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | 개시 | Wolfe Research | Underperform |
| 2022-06-01 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-12-16 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-06-10 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-12-15 | 업그레이드 | Goldman | Sell → Neutral |
| 2020-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | 업그레이드 | Stifel | Hold → Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-05-14 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2020-03-30 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2020-03-25 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Sell |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-02 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-06-05 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | 재확인 | Needham | Strong Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2019-01-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-12-19 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-08-27 | 재확인 | Argus | Buy |
모두보기
메드트로닉 주식(MDT)의 최신 뉴스
Medtronic Data Breach Exposes Personal Information: Murphy Law Firm Investigates Legal Claims - GlobeNewswire Inc.
Is Medtronic PLC (MDT) a Bargain After 3.3% Drop? GF Value Says Undervalued - GuruFocus
Medtronic PLC Stock (MDT) Closed Down by 3.30% on Jun 30: Key Drivers Unveiled - TradingKey
Medtronic reports solid Q4 earnings, shares steady ahead August update - AD HOC NEWS
Is Medtronic plc (MDT) A Good Stock To Buy Now? - Insider Monkey
Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic - MedTech Dive
Medtronic plc refines diabetes portfolio, shares reflect mixed analyst stance - AD HOC NEWS
MiniMed widens board as it builds out as an independent diabetes tech company - Stock Titan
Medtronic clears spin-off milestone, diabetes IPO plans keep the stock in focus - AD HOC NEWS
Here is Why Medtronic (MDT) is One of the Best Long Term Stocks to Buy According to Hedge Funds - Yahoo Finance
Medtronic: Coming Back, But Not Yet Ready For Greatness (NYSE:MDT) - Seeking Alpha
Is Medtronic (MDT) A Bargain After Renal Denervation Optimism And Strong Revenue Growth? - simplywall.st
Medtronic plc tariff impact clarified, shares stay anchored in S&P 500 context - Ad-hoc-news.de
Price to book forward of Medtronic plc. – NYSE:MDT - TradingView
Medtronic plc (MDT) CEO Discloses the Impacts of Tariffs on the Company - Insider Monkey
Medtronic adjusts to mixed analyst signals, shares hold steady on NYSE - Ad-hoc-news.de
Enterprise value to EBIT forward of Medtronic plc. – NYSE:MDT - TradingView
Medtronic Plc Actuals & Estimates (NYSE:MDT) - TradingView
Medtronic plc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh Actuals & Estimates (BMFBOVESPA:MDTC34) - TradingView
Medtronic PLC stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Medtronic (NYSE: MDT) EVP Kweli details shares, options and PSU holdings - Stock Titan
Why Did Medtronic Stock Fall Despite Beating Q3 Earnings - Kavout | AI
Enterprise value to revenue forward of Medtronic plc. – NYSE:MDT - TradingView
Medtronic reports strongest revenue growth in a decade, shares hold near S&P 500 peer levels - Ad-hoc-news.de
Meyer Handelman Co. Cuts Stock Position in Medtronic PLC $MDT - MarketBeat
Price to earnings forward of Medtronic Plc – LSX:A14M2J - TradingView
Enterprise value to revenue forward of Medtronic Plc – LSX:A14M2J - TradingView
Enterprise value to EBITDA forward of Medtronic Plc – LSX:A14M2J - TradingView
Medtronic raises guidance and shares trade higher on NYSE - Ad-hoc-news.de
Medtronic Plc Actuals & Estimates (BMV:MDT/N) - TradingView
Medtronic Plc Actuals & Estimates (MUN:2M6) - TradingView
Needham Remains Bullish On Medtronic (MDT) Amid Renal Device Growth - Insider Monkey
Medtronic | MDT Stock Price, Company Overview & News - Forbes
Medtronic PLC stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Medtronic reports strongest revenue growth in a decade, shares consolidate on NYSE - Ad-hoc-news.de
Medtronic appoints veteran J&J exec as first CFO of innovation - MedTech Dive
This Undervalued Medical-Devices Stock Is Poised for a Rebound - Barron's
Is It Worth Investing in Medtronic (MDT) Based on Wall Street's Bullish Views? - Yahoo Finance
Medtronic plc (MDT) Stock Analysis: Exploring a 23.52% Upside Potential Amid Strong Buy Ratings - DirectorsTalk Interviews
Medtronic (MDT) Completes $550M Acquisition of Scientia Vascular - Yahoo Finance
Medtronic (MDT) Stock Could Be 12.2% Undervalued After Strong Revenue Growth - simplywall.st
United States Pacemakers Market to Reach US$ 6.99 Billion by 2033 - openPR.com
Medtronic Introduces PulseSelect™ PFA Technology to address India’s Growing AFib and Stroke Burden - Passionate In Marketing
Medtronic completes acquisition of Scientia Vascular - Today's Medical Developments
Medtronic plc 2026 10-K Report: Financial Performance, Business Segments, and Global Operations Overview - Minichart
MDT News | MEDTRONIC PLC (NYSE:MDT) - ChartMill
American Society of Anesthesiologists Announces 12-Year Collaboration with Medtronic as a Corporate Supporter | Newswise - Newswise
[IRANNOTICE] Medtronic plc SEC Filing - Stock Titan
Medtronic PLC stock outperforms competitors on strong trading day - MarketWatch
Medtronic plc FY 2026: Revenue $36.36B, EPS $3.73— 10-K Summary - TradingView
Diabetes spin-off, AI and regulation reshape Medtronic (MDT) medical device strategy - Stock Titan
메드트로닉 (MDT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.74%
자본화:
|
볼륨(24시간):